First Horizon Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.9K | Sell |
1,457
-621
| -30% | -$30.2K | ﹤0.01% | 831 |
|
|
2025
Q1 | $70.7K | Buy |
2,078
+39
| +2% | +$1.33K | ﹤0.01% | 794 |
|
|
2024
Q4 | $80.3K | Buy |
2,039
+511
| +33% | +$20.1K | ﹤0.01% | 759 |
|
|
2024
Q3 | $71.8K | Sell |
1,528
-44
| -3% | -$2.07K | ﹤0.01% | 841 |
|
|
2024
Q2 | $84.9K | Buy |
1,572
+136
| +9% | +$7.35K | ﹤0.01% | 726 |
|
|
2024
Q1 | $97.9K | Buy |
1,436
+8
| +0.6% | +$545 | ﹤0.01% | 699 |
|
|
2023
Q4 | $89.4K | Sell |
1,428
-127
| -8% | -$7.95K | ﹤0.01% | 702 |
|
|
2023
Q3 | $70.6K | Sell |
1,555
-542
| -26% | -$24.6K | ﹤0.01% | 725 |
|
|
2023
Q2 | $118K | Sell |
2,097
-574
| -21% | -$32.2K | ﹤0.01% | 600 |
|
|
2023
Q1 | $121K | Buy |
2,671
+513
| +24% | +$23.2K | ﹤0.01% | 594 |
|
|
2022
Q4 | $87.7K | Sell |
2,158
-287
| -12% | -$11.7K | ﹤0.01% | 659 |
|
|
2022
Q3 | $159K | Sell |
2,445
-543
| -18% | -$35.3K | 0.01% | 493 |
|
|
2022
Q2 | $181K | Buy |
+2,988
| New | +$181K | 0.01% | 483 |
|
|
2022
Q1 | – | Sell |
-986
| Closed | -$74K | – | 1817 |
|
|
2021
Q4 | $74K | Buy |
986
+190
| +24% | +$14.3K | ﹤0.01% | 782 |
|
|
2021
Q3 | $89K | Buy |
796
+215
| +37% | +$24K | ﹤0.01% | 709 |
|
|
2021
Q2 | $93K | Buy |
581
+159
| +38% | +$25.5K | 0.01% | 563 |
|
|
2021
Q1 | $51K | Buy |
+422
| New | +$51K | ﹤0.01% | 733 |
|